The largest database of trusted experimental protocols

Amicon centrifugal filter device

Manufactured by Merck Group
Sourced in United States, Germany

Amicon centrifugal filter devices are laboratory equipment used for the separation and concentration of macromolecules, such as proteins and nucleic acids, from complex solutions. These devices utilize centrifugal force to pass the sample through a semipermeable membrane, allowing the desired molecules to be retained while smaller components are filtered out.

Automatically generated - may contain errors

28 protocols using amicon centrifugal filter device

1

SILAC Proteomic Analysis of Cell Secretome

Check if the same lab product or an alternative is used in the 5 most similar protocols
M and S cells were cultured in L-lysine and L-arginine-depleted RPMI (Thermo Scientific, Hudson, NH) supplemented with 10% dialyzed FBS, antibiotics (PAA), and either 0.1 mg/mL 12C6- (M) or 0.1 mg/mL 13C6- (S), L-lysine and L-arginine (Thermo). The medium was replaced every 2 days, and cells routinely passaged at 80-90% confluence. After 14 days, cells were cultured for 2 days in light (M) or heavy (S) labeled medium without FBS, conditioned mediums collected, centrifuged, filtered through a 0.2 μm filter (VWR) and concentrated using Amicon centrifugal filter devices with a 3-kDa molecular weight cut-off (Millipore, Billerica, MA). Protein content was quantified (Bradford RcDc protein assay; BioRad, Hercules, CA) and 15 μg of each sample were mixed, diluted in 50 mM ammonium bicarbonate and concentrated using an Amicon centrifugal filter device with a 10-kDa molecular weight cut-off (Millipore). The <10 kDa fraction was evaporated to dryness, resuspended in 8 M urea, 50 mM ammonium bicarbonate, reduced with 50 mM dithiothreitol, alkylated with 125 mM iodoacetamide, digested with trypsin and analysed by LC-MS. The >10 kDa fraction was resuspended in loading buffer and subjected to electrophoresis on a 12.5% SDS-polyacrylamide gel.
+ Open protocol
+ Expand
2

Characterization of iTEP Carrier Size

Check if the same lab product or an alternative is used in the 5 most similar protocols
The size distributions of iTEP carriers were determined by dynamic light scattering (DLS) using a Zetasizer Nano-ZS instrument (Malvern Instruments, Malvern, UK) as previously described [11 (link)]. For iTEP carrier samples without cysteine residues, we resuspended them at various concentrations in PBS and keep them at room temperature overnight before conducting measurements. For iTEP carrier samples with cysteine residues, we first fully reduced the disulfide bonds within them. Then, we set their concentrations to 100 μM and confirmed that the samples formed NPs. Next, we oxidized these samples with 0.3% H2O2 at 37 °C for 15 min and generated disulfide bonds to stabilize the NPs. Last, we removed the H2O2 from samples through centrifugation with Amicon centrifugal filter devices (Millipore, USA). To test the effect of GSH on iTEP NP formation, 5 μM oxidized iTEP carriers in PBS were treated overnight with different concentrations of GSH at 37 °C before measurement. The reported results represented the average particle size by number. Other parameters including Z-average, size by intensity, and size by volume were also measured and reported in Supplementary Table S2 and S4.
+ Open protocol
+ Expand
3

Purification of Recombinant SPARC Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293T cells bearing integrated copies of a human SPARC expression vector [68 (link)] were grown in DMEM supplemented with 10% FBS and 3 μg/mL puromycin. Confluent cells were grown in serum- and puromycin-free medium and conditioned medium harvested every 2 or 3 days for 7–8 harvests and concentrated 10-fold on 30,000 Da cut-off Amicon centrifugal filter devices (Millipore) with simultaneous exchange into starting buffer (20 mM MOPS, 200 mM LiCl, pH 6.5). Concentrates were bound to a Maxi Anion (Q) Spin Column (Thermo) equilibrated with starting buffer and eluted with 30% elution buffer (20 mM MOPS, 400 mM LiCl, pH 6.5). SPARC-containing fractions, monitored by SDS-PAGE, were concentrated and dialyzed against Hank’s balanced salt solution (HBSS).
+ Open protocol
+ Expand
4

ECFC VWF Secretion Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of VWF:Ag secreted into media of 6 healthy ECFCs (each, 3 different samples from cell passages 6 to 10; N = 18) and IP-ECFCs (3 different ECFCs isolation in 2014, 2018, and 2020; each, 3 samples from cell passages of 6 to 10; N = 9) were measured. Seventy-two hours after seeding cells (at a density of 1.5 × 106 cells/10 mL per 75-cm2 flasks), the supernatant medium was collected and cells were lysed. Subsequently, the collected medium was concentrated on Amicon Centrifugal filter devices (Millipore, USA). Considering variations in cell proliferation rates (and its impact on doubling population) the VWF:Ag levels were normalized using total ECFCs lysates cellular protein content, after performing Bradford assay (Coomassie Plus Assay Kit; Thermo Scientific, USA). Furthermore, the secreted VWF multimers were analyzed by electrophoresis on 1.2% and 1.6% sodium dodecyl sulfate (SDS)-agarose gel.22,23 (link)
+ Open protocol
+ Expand
5

In Vivo Biodistribution of Exosomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 200 µl of exosomes from the control groups were mixed and incubated with 1-µM DiR (Invitrogen, USA) for 30 min at room temperature. Free DiR was then removed from DiR-labeled exosomes by using Amicon centrifugal filter devices (Millipore, USA). After fish anesthesia with benzocaine, the DiR-labeled exosomes were injected into three healthy fish (average weight, 1.2 g) at the posterior dorsal aorta by a microinjection system (WPI PV820, USA) with a dose of 8 µl/fish. After 6 h, the fluorescence images of live fish body from both dorsal and ventral sides and major organs after dissection were recorded by IVIS (Wilber NEWTON 7.0, France).
+ Open protocol
+ Expand
6

Preparation of Peptide/A^q Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

Preparation of Peptide/Aq Complexes

Empty soluble Aq molecules were loaded with 5 to 50-fold molar excess of GalOK264 CII259-273, non-modified CII259-273 or MOG79-90 peptides at 4° C. for 72 h. GalOK264 CII259-273 is a peptide from type II collagen (CII) position 259-273 which has a lysine at position 264, which is hydroxylated and galactosylated.

Non-modified is the same peptide but with a lysine without modifications of its side chain. MOG=myelin oligodendrocytic glycoprotein. MHC-peptide complexes were separated by anion-exchange HPLC (Resource™ Q column) using an ÄKTA™ explorer 100 Air system (Amersham Pharmacia Biotech AB, Uppsala, Sweden) with UNICORN V4.00 software. Separations were done with a loading solution of 10 mM Tris pH 8.5 (buffer A) and a gradient elution up to 1 M NaCl (buffer B) in 10 mM Tris. The eluted protein fractions were concentrated by ultrafiltration (MICROSEP 30K OMEGA), dialyzed against PBS and examined by ELISA, SDS-PAGE and T-cell hybridoma tests. MHC-peptide complexes were purified further on a Superdex 200 gel filtration column (Amersham Pharmacia Biotech AB, Uppsala, Sweden), concentrated again by Amicon® centrifugal filter devices (MILLIPORE Co, Billerica, Mass.) and stored at −20° C. until used.

+ Open protocol
+ Expand
7

Characterization of VWF Secretion in ECFCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The VWF levels secreted into the supernatant media and present in the cell lysates of the six healthy ECFCs (three different samples each; N = 18) and IP-ECFCs (six samples from various cell passages, the same as the passage numbers of the healthy individuals; N = 6) were determined. Seventy-two hours after seeding cells (at a density of 1.5 × 106 cells/10 mL in 75 cm2 flasks), the supernatant medium was collected, and cells were lysed. VWF present in media and cell lysates was concentrated on Amicon centrifugal filter devices (Millipore, Burlington, MA, USA), VWF:Ag levels were measured, and VWF multimers were analyzed by electrophoresis on 1.2% and 1.6% SDS-agarose gel [33 (link),64 (link)].
+ Open protocol
+ Expand
8

Recombinant Dianthin-EGF Fusion Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Dia-EGFpET11d plasmid was transformed into Escherichia coli Rosetta DE pLysS (Novabiochem, Schwalbach, Germany) [14 (link)]. Cells were incubated overnight at 30 °C in Lysogeny Broth (LB) containing 100 mg/mL ampicillin. Cells were centrifuged (5 min, 3000 g) and then the pellet was dissolved in 2 L of LB containing 50 mg/mL ampicillin. Cells were grown overnight to a final optical density of 0.8. Isopropyl β-D-1-thiogalactopyranoside (IPTG, 2 mL, 1 M) was added for 3 h at 30 °C. Cell harvests were obtained by centrifugation (10 min, 5000 g, 4 °C). Cell pellets were resuspended in 20 mL phosphate-buffered saline (PBS, pH 7.4) at 20 °C. Fusion proteins were released from the FRENCH Press at 1500 psi after thawing. The solution was centrifuged (30 min, 4 °C) and adjusted with 10 mM imidazole. The construct applied to nickelnitrilotriacetate chromatography (Ni-NTA Agarose, Qiagen, Hilden, Germany). The fractions were analyzed by SDS-PAGE (12%) after elution with imidazole (20–250 mM). The fraction containing dianthin-EGF (DE) was concentrated in Amicon centrifugal filter devices (30 kDa Millipore, Eschborn, Germany). Imidazole was removed by buffer exchange (PBS) with PD10 columns (GE Healthcare, Munich, Germany). A BCA assay (Pierce, Rockford, IL, USA) was used to determine the protein concentration.
+ Open protocol
+ Expand
9

Exploring AGE-albumin Effects on Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
hBD-MSCs were passaged 5–6 times and cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) containing a low glucose concentration supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% gentamycin. Then, hBD-MSCs were incubated with basal medium (BM, Gibco) with serum (conditioned medium; CM) and with 800 μg/ m AGE-albumin (AA/CM) with or without 400 ng/ m sRAGE (AA/CM/sRAGE) for two days. These medium were collected in a conical centrifuge tube and cell debris was discarded. Supernatants were concentrated by Amicon centrifugal filter devices (Millipore, USA) following the manufacture’s protocol.
Human umbilical vein endothelial cells (HUVECs; CEFObio, Seoul, Korea) were cultivated with EGMTM-2 growth medium including bovine brain extract with heparin, human epithelial growth factor, hydrocortisone and GA-1000 (Lonza, Walkersville, MD) in a 1% gelatin (Sigma-Aldrich, St Louis, MO) coated culture dish. Murine macrophage cells (Raw 264.7) and rattus norvegicus skeletal muscle cells (L6) were also used in this study. These cells were purchased from Korean Cell Line Bank and cultured in DMEM with a high glucose concentration supplemented with 10% FBS and 100 U/ m penicillin and 100 μg  m streptomycin. All cells were maintained in a 5% CO2 humidified incubator at 37 °C.
+ Open protocol
+ Expand
10

HIV Antigen Conjugation to DEC-205 Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified HIVtop4 protein was conjugated to monovalent anti DEC-205 (Rat anti mouse DEC-205; IgG2a, clone NLDC145) or isotype matched control antibody (RTK2758) (Biolegend, USA) using Schiff base formation and reductive amination according to standard protocol (26 ). In brief, first anti DEC-205 or isotype matched control monoclonal antibodies were reduced using 100 mM 2-mercaptoethanesulfonic acid sodium salt (MESNA; Sigma-Aldrich) for 30 min at 37°C and separated from the reducing agent over a desalting column. Then, these monovalent antibodies were oxidized at their carbohydrate residues using sodium periodate (sigma-aldrich) for production of aldehyde functional groups and separated from the oxidative agent over a desalting column. Purified HIVtop4 protein was added to the modified antibodies, and 5M sodium borohydride (sigma-aldrich) as reducing agent was used to facilitate schiff base intermediates formation and conjugation of protein to antibody. Antibody: HIVtop4 conjugates purified by dialysis using sterile Phosphate Buffered Saline (PBS) and passed over an Amicon centrifugal filter devices (cut off 50 kDa) (Millipore, Germany) to remove unconjugated protein, and then evaluated by spectrophotometry, SDS-PAGE, western blotting and ELISA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!